Insuman Komb 15 Gt

Insuman Comb 15 GT: Description and features

Insuman Comb 15 GT is an intermediate-acting insulin produced in Germany. It belongs to the pharmaceutical group of intermediate-acting insulins and is a biphasic insulin obtained by genetic engineering based on the human gene.

The manufacturer of Insuman Comb 15 GT is Hoechst Marion Roussel GmbH, located in Germany. This drug is also known under various synonyms, including Gansulin 30P, Insulin Humulin M2, Insulin Humulin M3, Insuman Comb 25 GT, Insuman Comb 50 GT, Mixtard 10 HM penfill, Mixtard 20 HM penfill, Mixtard 30 HM, Mixtard 30 HM penfill, Mixtard 40 HM penfil, Mixtard 50 HM penfil and Humulin M2, Humulin M3.

Insuman Comb 15 GT is presented in the form of an injection suspension containing 100 U/ml insulin. An injection suspension with a concentration of 40 units/ml is also available.

Intermediate-acting insulins, such as Insuman Comb 15 GT, play an important role in the treatment of diabetes mellitus. They help regulate blood glucose levels by controlling its uptake into tissues and enhancing the formation of glycogen in the liver.

Before using Insuman Comb 15 GT, you should consult your doctor or endocrinology specialist. They will help determine the correct dosage and regimen of drug administration, taking into account the individual characteristics of the patient.

It is important to follow the instructions for use of Insuman Comb 15 GT and store it correctly in accordance with the manufacturer's recommendations. Also regularly monitor your blood glucose levels and follow other doctor's recommendations to maintain stable health.

In conclusion, Insuman Comb 15 GT is an intermediate acting insulin manufactured in Germany. It effectively helps control blood glucose levels in patients with diabetes. However, before using it, you should consult your doctor and follow the instructions for use to achieve the best treatment results.